Harnessing genomics to improve outcomes for women with cancer in India: key priorities for research.

导出原文传递

翻译打印收藏纠错

作者： Sudha,Sundar ^[1] ; Poonam,Khetrapal-Singh ^[2] ; Jon,Frampton ^[3] ; Edward,Trimble ^[4] ; Preetha,Rajaraman ^[4] ; Ravi,Mehrotra ^[5] ; Roopa,Hariprasad ^[5] ; Arindam,Maitra ^[6] ; Paramjit,Gill ^[7] ; Vanita,Suri ^[8] ; Radhika,Srinivasan ^[9] ; Gurpreet,Singh ^[10] ; J S,Thakur ^[11] ; Preet,Dhillon ^[12] ; Jean-Baptiste,Cazier ^[13]

作者单位： Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. Electronic address: s.s.sundar@bham.ac.uk. ^[1] World Health Organization Regional Office for Southeast Asia, New Delhi, India. ^[2] Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. ^[3] National Cancer Institute, Bethesda, MD, USA. ^[4] National Institute of Cancer Prevention and Research, Noida, Uttar Pradesh, India. ^[5] National Institute of Biomedical Genomics, Kolkata, West Bengal, India. ^[6] Institute of Applied Health, University of Birmingham, Birmingham, UK. ^[7] Department of Obstetrics and Gynaecology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. ^[8] Department of Pathology and Cytology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. ^[9] Department of Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India. ^[10] Department of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh, India. ^[11] Public Health Foundation, Gurugram, Haryana, India. ^[12] Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK. ^[13]